Anna Gillio‐Tos
Impact in
- Epidemiology top 1%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Microbiology top 1%
- Reproductive tract infections research
Papers in
-
- Reproductive tract infections research 5
- Epidemiology 32
- Cervical Cancer and HPV Research 30
- Hepatitis B Virus Studies 9
- Co-authors
- Guglielmo RoncoLaura De MarcoAnnarosa Del MistroNereo SegnanPaolo Giorgi RossiMassimo ConfortiniFranco MerlettiManuel Zorzi
- Journals
- PLoS ONE (7 papers)Journal of Clinical Virology (4 papers)European Journal of Cancer (3 papers)The Lancet Oncology (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- ItalyUnited KingdomFrance
In The Last Decade
Anna Gillio‐Tos
50 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Epidemiology 2.1k
- Microbiology 358
- Obstetrics and Gynecology 264
- Surgery 1.0k
- Oncology 578
Countries citing papers authored by Anna Gillio‐Tos
This map shows the geographic impact of Anna Gillio‐Tos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gillio‐Tos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gillio‐Tos more than expected).
Fields of papers citing papers by Anna Gillio‐Tos
This network shows the impact of papers produced by Anna Gillio‐Tos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gillio‐Tos. The network helps show where Anna Gillio‐Tos may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Gillio‐Tos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2018 | 6 | |
| 3 | 2016 | 8 | |
| 4 | 2016 | 3 | |
| 5 | 2015 | 23 | |
| 6 | [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)]. | 2015 | 0 |
| 7 | 2013 | 32 | |
| 8 | 2013 | 21 | |
| 9 | 2013 | 22 | |
| 10 | [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. | 2012 | 55 |
| 11 | Health Technology assessment Report: Ricerca del dna di papillomavirus umano (HPV) come test primario per lo screening dei precursori del cancro del collo dell'utero. | 2012 | 2 |
| 12 | 2012 | 39 | |
| 13 | 2008 | 140 | |
| 14 | 2007 | 51 | |
| 15 | 2007 | 60 | |
| 16 | 2006 | 242 | |
| 17 | 2006 | 18 | |
| 18 | 2006 | 31 | |
| 19 | 2004 | 102 | |
| 20 | Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings. | 1992 | 3 |
About Anna Gillio‐Tos
Anna Gillio‐Tos is a scholar working on Microbiology, Epidemiology, Urology, Surgery and Hepatology, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (30 papers), Genital Health and Disease (14 papers), Epigenetics and DNA Methylation (12 papers), Hepatitis B Virus Studies (9 papers), Molecular Biology Techniques and Applications (6 papers), Reproductive tract infections research (5 papers), Prostate Cancer Treatment and Research (5 papers) and Global Cancer Incidence and Screening (4 papers). The work is most often cited by research in Epidemiology (2.1k citations), Microbiology (358 citations), Obstetrics and Gynecology (264 citations), Surgery (1.0k citations) and Oncology (578 citations). Anna Gillio‐Tos has collaborated with scholars based in Italy, United Kingdom and France. Frequent co-authors include Guglielmo Ronco, Laura De Marco, Annarosa Del Mistro, Nereo Segnan, Paolo Giorgi Rossi, Massimo Confortini, Franco Merletti, Manuel Zorzi, Jack Cuzick and Carlo Naldoni. Their work appears in journals such as PLoS ONE, Journal of Clinical Virology, European Journal of Cancer, The Lancet Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.